Increased type I procollagen mRNA transcripts in the lungs of mice during the development of bleomycin-induced fibrosis

In this study, in situ hybridization has been used to investigate the localization of type I procollagen messenger ribonucleic acid (mRNA) in normal lung, and in the lungs of mice during the development of bleomycin-induced pulmonary fibrosis. Lung fibrosis was induced by a single intratracheal instillation of bleomycin sulphate (6 mg.kg-1 body weight), and tissues examined at times up to 35 days thereafter. Tissue transcripts of alpha 2(I) procollagen mRNA were visualized after hybridization with 35S-labelled riboprobes. Hybridization signals were associated with alveolar interstitial cells throughout the normal lung, with additional areas of dense hybridization signals observed subpleurally. Three days following administration of bleomycin, there was no apparent change in the pattern of hybridization. By 10 days, foci of intense hybridization signals indicative of gene activation were observed associated with individual cells in the alveolar interstitium. At 21 days, the increase in hybridization signals appeared to be associated with greater numbers of cells rather than highly activated cells. These results demonstrate that procollagen genes are normally expressed in the mouse lung, and that during bleomycin-induced pulmonary fibrosis hybridization signals increase, suggesting that both enhanced gene expression by individual cells and increased numbers of cells expressing the type I procollagen gene are involved in the pathogenetic mechanism.

This article has been cited by other articles:

				E. R. Parra, W. R. Teodoro, A. P. P. Velosa, C. C. de Oliveira, N. H. Yoshinari, and V. L. Capelozzi Interstitial and Vascular Type V Collagen Morphologic Disorganization in Usual Interstitial Pneumonia J. Histochem. Cytochem., December 1, 2006; 54(12): 1315 - 1325. [Abstract] [Full Text] [PDF]

				E. G. Tzortzaki, A. V. Koutsopoulos, K. I. Dambaki, I. Lambiri, M. Plataki, M. K. Gordon, D. R. Gerecke, and N. M. Siafakas Active Remodeling in Idiopathic Interstitial Pneumonias: Evaluation of Collagen Types XII and XIV J. Histochem. Cytochem., June 1, 2006; 54(6): 693 - 700. [Abstract] [Full Text] [PDF]

				C. Jakubzick, E. S. Choi, B. H. Joshi, M. P. Keane, S. L. Kunkel, R. K. Puri, and C. M. Hogaboam Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells J. Immunol., September 1, 2003; 171(5): 2684 - 2693. [Abstract] [Full Text] [PDF]

				H. S. ALHO, K. A. INKINEN, U.-S. SALMINEN, P. K. MAASILTA, E. I. TASKINEN, V. GLUMOFF, E. I. VUORIO, T. S. IKONEN, and A. L. J. HARJULA Collagens I and III in a Porcine Bronchial Model of Obliterative Bronchiolitis Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1519 - 1525. [Abstract] [Full Text] [PDF]

				R. Koslowski, U. Pfeil, H. Fehrenbach, M. Kasper, E. Skutelsky, and K-W. Wenzel Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat Eur. Respir. J., August 1, 2001; 18(2): 347 - 356. [Abstract] [Full Text] [PDF]

				N. Kaminski, J. D. Allard, J. F. Pittet, F. Zuo, M. J. D. Griffiths, D. Morris, X. Huang, D. Sheppard, and R. A. Heller Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis PNAS, February 15, 2000; 97(4): 1778 - 1783. [Abstract] [Full Text] [PDF]